Dabigatran-etexilate-cntr-label-150mg (Dabigatran Etexilate Cntr Label 150mg)
Dabigatran Capsule
Product Images NDC 72205-202
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dabigatran (NDC 72205-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Dabigatran-etexilate-cntr-label-75mg (Dabigatran Etexilate Cntr Label 75mg)
Dabigatran-etexilate-crtn-label-150mg (Dabigatran Etexilate Crtn Label 150mg)
This text provides detailed information about Dabigatran Etexilate Capsules. It includes guidance on dosage, storage instructions, expiration after opening, and emphasizes non-substitutability with other forms of dabigatran. The text also lists the active ingredient content per capsule, manufacturer details, and contact information for distribution. The prescription-only medication is to be dispensed with a Medication Guide, and patients are advised to swallow the capsule whole.*
Dabigatran-etexilate-crtn-label-75mg (Dabigatran Etexilate Crtn Label 75mg)
This is information about Dabigatran Etexilate Capsules, a medication dispensed by pharmacists for patients. The capsules should be swallowed whole and used within 4 months of opening. They are not interchangeable with other forms of dabigatran etexilate on a mg-to-mg basis. Each capsule contains 75 mg of dabigatran etexilate. The usual dosage can be found in the package insert. The capsules should be stored at 25°C (77°F), with excursions permitted to 15° - 30°C (59° - 86°F). It is important to keep the bottle tightly closed in the original package to protect from moisture. The product is distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ, USA. The manufacturer is WISN Laboratories in Telangana, India. The information was issued on 0512024.*
Dabigatran-etexilate-figure-1 (Dabigatran Etexilate Figure 1)
Dabigatran-etexilate-figure-2 (Dabigatran Etexilate Figure 2)
Dabigatran-etexilate-figure-3-1 (Dabigatran Etexilate Figure 3 1)
Dabigatran-etexilate-figure-3-2 (Dabigatran Etexilate Figure 3 2)
Not available.*
Dabigatran-etexilate-figure-4 (Dabigatran Etexilate Figure 4)
Dabigatran-etexilate-figure-5 (Dabigatran Etexilate Figure 5)
Dabigatran-etexilate-structure (Dabigatran Etexilate Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
